Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:26
Drug Approvals
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20184119
- Approval Date
- Jul 17, 2023
NMPA
Oral Rehydration Salts Powder（Ⅲ）
- Product Name
- 口服补液盐散(Ⅲ)
- Approval Number
- 国药准字H20173390
- Approval Date
- Nov 25, 2022
NMPA
Ambroxol Hydrochloride Dispersible Tablets
- Product Name
- 必与
- Approval Number
- 国药准字H20060369
- Approval Date
- May 11, 2021
NMPA
Fasudil Hydrochloride Injection
- Product Name
- 盐酸法舒地尔注射液
- Approval Number
- 国药准字H20153101
- Approval Date
- Apr 28, 2020
NMPA
Pioglitazone Hydrochloride Dispersible Tablets
- Product Name
- 盐酸吡格列酮分散片
- Approval Number
- 国药准字H20100033
- Approval Date
- Sep 14, 2019
NMPA
Potassium Aspartate Injection
- Product Name
- 门冬氨酸钾注射液
- Approval Number
- 国药准字H20193165
- Approval Date
- Jun 6, 2019
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found